The short version
Unlike Wegovy for weight loss (which requires the cardiovascular indication under Medicare), Ozempic and Mounjaro for type 2 diabetes have been covered under Medicare Part D since their original FDA approvals. The Medicare copay for Tier 3 GLP-1s is typically $50-$100 monthly. Most general telehealth programs don't bill Medicare; the programs below do, and code the prescription for diabetes (E11.9) correctly so the Part D pharmacy fills it.
What we considered
- Handles Medicare Part D billing for diabetes-indicated GLP-1
- Codes the diagnosis correctly (E11.9 type 2 diabetes)
- Coordinates with the patient's endocrinologist or primary care doctor
- Manages A1C-driven dose adjustments
Top pick: 9amHealth
9amHealthDiabetes and cardio specialist. $75/mo via insurance with T2D or CV diagnosis.
Starts From
$25/mo+ medication separateLock-In
Month-to-monthScore
7.4
9amHealth specifically targets patients with type 2 diabetes, prediabetes and cardiovascular risk; handles Medicare Part D billing as standard practice.
Read the full 9amHealth review →
Other strong picks
Form HealthForm Health's obesity-medicine specialists also cover diabetes co-management and bill Medicare Part D for Ozempic and Mounjaro.
Starts From
$299/mo+ med separateLock-In
Month-to-monthScore
7.6
KnownwellKnownwell's full primary-care model includes T2D management on Medicare with appropriate dose titration and A1C monitoring.
Starts From
Insurance-billed+ med separateLock-In
Month-to-monthScore
7.5
PlushCarePlushCare bills Medicare for diabetes-indicated GLP-1s and is in-network with most Medicare Advantage plans.
Starts From
$19.99/mo+ med separateLock-In
Month-to-monthScore
7.2
Related
Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each program's public-facing page weekly.